Human LGALS3BP(Lectin Galactoside Binding, Soluble 3 Binding Protein) CLIA Kit

Human LGALS3BP (Lectin Galactoside Binding, Soluble 3 Binding Protein) CLIA Kit is a highly sensitive and specific diagnostic tool designed for the quantitative measurement of LGALS3BP in human serum, plasma, and other biological fluids. This kit is based on the Chemiluminescent Immunoassay (CLIA) technology, which utilizes a solid-phase sandwich enzyme-linked immunosorbent assay (ELISA) principle.

The kit contains all the necessary reagents and components required for the assay, including pre-coated microplates, standards, controls, and detection antibodies. The LGALS3BP CLIA Kit has a wide dynamic range of detection, with a lower limit of detection of 0.05 ng/mL and an upper limit of 100 ng/mL. The assay is highly reproducible, with intra-assay and inter-assay coefficients of variation of less than 10%. The LGALS3BP CLIA Kit is intended for research use only and is not intended for diagnostic or therapeutic purposes. This kit is an essential tool for researchers studying the role of LGALS3BP in various diseases, including cancer, inflammation, and cardiovascular diseases.